Preparing and timing of the endometrium in modified natural cycle frozen-thawed embryo transfers (mNC-FET) - a randomized controlled multicenter trial - FET OPT

Anja Bisgaard Pinborg0 个研究点目标入组 670 人开始时间: 2018年6月15日最近更新: 2024年2月19日

适应症

试验速览

暂无简介。

•Inclusion criteria
•? Female age 18-41 years
•? Regular menstrual cycle (23-35 days)
•? Vitrified blastocysts derived from 1.-3. IVF/ICSI cycle resulting in an embryo transfer in a public hospital
•? Undergoing single blastocyst transfer.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 670
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Previous participation in the study, uterine malformations, intrauterine polyps or submucosal myomas, breast feeding, oocyte donation, preimplantation genetic testing, blastocyst conceived with sperm from testicular sperm aspiration, HIV (woman), hepatitis B and C (woman), known luteal phase insufficiency or if patients are not fulfilling the inclusion criteria. Further exclusion criteria are the following contraindications to progesterone; allergy to the study medication, undiagnosed vaginal bleeding, current missed abortion or ectopic pregnancy, hepatic insufficiency or severe hepatic disease, genital or breast cancer, arterial or venous thromboembolism, thrombophlebitis or porphyria. For patients participating in the sub-study, thyroid disease is an exclusion criterion.

发起方

Anja Bisgaard Pinborg